Kantoff PW - Search Results

1

A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status.

Stopsack KH, Gonzalez-Feliciano AG, Peisch SF, Downer MK, Gage RA, Finn S, Lis RT, Graff RE, Pettersson A, Pernar CH, Loda M, Kantoff PW, Ahearn TU, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Stopsack KH, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1231-1233. doi: 10.1158/1055-9965.EPI-18-0510. Epub 2018 Aug 14. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 30108097 Free PMC article.

2

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. Among authors: kantoff pw. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455

3

Prostate cancer.

Kantoff PW. Kantoff PW. Trans Am Acad Insur Med. 1993;76:64-72. Trans Am Acad Insur Med. 1993. PMID: 8337772 Review. No abstract available.

4

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. Kantoff PW, et al. Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):189-92. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9138662

5

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.

Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Talcott JA, et al. Among authors: kantoff pw. J Clin Oncol. 1998 Jan;16(1):275-83. doi: 10.1200/JCO.1998.16.1.275. J Clin Oncol. 1998. PMID: 9440753

6

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. Platz EA, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610786 Clinical Trial.

7

Debrisoquine hydroxylase (CYP2D6) and prostate cancer.

Febbo PG, Kantoff PW, Giovannucci E, Brown M, Chang G, Hennekens CH, Stampfer M. Febbo PG, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1075-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865424

8

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

Kantoff PW, Halabi S, Conaway M, Picus J, Kirshner J, Hars V, Trump D, Winer EP, Vogelzang NJ. Kantoff PW, et al. J Clin Oncol. 1999 Aug;17(8):2506-13. doi: 10.1200/JCO.1999.17.8.2506. J Clin Oncol. 1999. PMID: 10561316 Clinical Trial.

9

The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.

Febbo PG, Kantoff PW, Platz EA, Casey D, Batter S, Giovannucci E, Hennekens CH, Stampfer MJ. Febbo PG, et al. Among authors: kantoff pw. Cancer Res. 1999 Dec 1;59(23):5878-81. Cancer Res. 1999. PMID: 10606227 Clinical Trial.

10

No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study.

Shepard TF, Platz EA, Kantoff PW, Nelson WG, Isaacs WB, Freije D, Febbo PG, Stampfer MJ, Giovannucci E. Shepard TF, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1267-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097238 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters